Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Health Insurance

Customers of genetic testing company 23andMe are caught in DNA limbo

Your article was successfully shared with the contacts you provided.

There has been little word from 23andMe since the Food and Drug Administration ordered the company to stop marketing its $99 genetic test kit. The company’s CEO issued a blog promising to address the FDA’s concerns, but what does that mean for 23andMe customers who have either received results or are currently waiting for test results?